Beryl Therapeutics: Funding, Investors & Team (Oct 2026)
Beryl Therapeutics goal is to open up a new frontier in bone health based on the revelation that lipids are crucial signaling molecules that play a role in bone mass regulation. Beryl is developing a patented first-in-class small molecule to increase peak bone mass and cure poor bone mineral density caused by disease or natural aging.
Beryl Therapeutics has raised $250k across 1 funding round on record, the most recent an undisclosed round of $250k announced in May 2023.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Beryl Therapeutics Company Profile and Key Stats
Latest funding round on record: May 2023.
Beryl Therapeutics Funding Rounds
Beryl Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Beryl Therapeutics Funding Compared to Other Biotechnology Startups
Beryl Therapeutics' latest round of $250k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Beryl Therapeutics in Biotechnology and Longmont
Companies Similar to Beryl Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Beryl Therapeutics Funding FAQs
What does Beryl Therapeutics do?
Beryl Therapeutics goal is to open up a new frontier in bone health based on the revelation that lipids are crucial signaling molecules that play a role in bone mass regulation. Beryl is developing a patented first-in-class small molecule to increase peak bone mass and cure poor bone mineral density caused by disease or natural aging.
How much funding has Beryl Therapeutics raised?
Beryl Therapeutics has raised $250k across 1 round on record. The most recent is an undisclosed round of $250k announced in May 2023.
When did Beryl Therapeutics last raise funding?
Beryl Therapeutics' most recent funding round on record is an undisclosed round of $250k, announced in May 2023.
Who founded Beryl Therapeutics?
FundedIQ lists Allison Drew Klein (Founder) at Beryl Therapeutics.
Where is Beryl Therapeutics headquartered?
Beryl Therapeutics is based in Longmont, Colorado, United States.
How many employees does Beryl Therapeutics have?
Beryl Therapeutics is in the 1-10 employee band.
How does Beryl Therapeutics' funding compare to other Biotechnology startups?
Beryl Therapeutics' latest round of $250k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Beryl Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Beryl Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.